VahatiCor
CA - Santa ClaraBiotechnology
Focus: Refractory Angina Treatment Device
VahatiCor is a life sciences company focused on Refractory Angina Treatment Device.
Profile data last refreshed 4h ago
Open Jobs
8+3 this month
Stable — net +3 jobs in 30d
3 added, 0 removed. Backfill posture.
Data completeness
2/9 — Limited
Company HealthSolid
Pipeline
Early-stage
2 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
A-FLUX Reducer System
Angina PectorisClinical Trials (1)
NCT07449325Self Expanding Coronary Sinus Reducer for Treatment of Symptomatic Coronary Microvascular Dysfunction (CMD)
N/AHelp build intelligence for VahatiCor
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.